A carregar...
Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years
Randomized trials demonstrated the superiority of chemoimmunotherapy over chemotherapy in the frontline treatment of CLL. Based on favorable experience with the addition of mitoxantrone (M) to fludarabine (F) plus cyclophosphamide (C), we designed a pilot study testing the combination of FCM plus ri...
Na minha lista:
| Publicado no: | Leuk Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845644/ https://ncbi.nlm.nih.gov/pubmed/19646755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2009.07.008 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|